SCHEMBL6984637

SCHEMBL6984637

Nc1nc(N)nc(-c2cccc(-n3cccc3)c2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.54
MAPT P10636 2/20 0.52
ADORA2A P29274 2/20 0.50
POLB P06746 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
ADORA2B P29275 1/20 0.50
ADORA1 P30542 1/20 0.50
GAA P10253 1/20 0.49
NPC1 O15118 3/20 0.43
AOC2 O75106 2/20 0.41
HRH4 Q9H3N8 3/20 0.40
PIK3CA P42336 1/20 0.39
DHFR P00374 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15021470 0.87 GAA (0.51) RAB9AMAPTPOLBGAANPC1
SCHEMBL10498584 0.79 GAA (0.46) RAB9AMAPTPOLBGAANPC1
SCHEMBL4801904 0.79 RAB9A (0.73) RAB9AMAPTADORA2APOLBADORA3
SCHEMBL15021487 0.79 FFAR4 (0.46) RAB9AMAPTGAANPC1AOC2
SCHEMBL28560915 0.77 RAB9A (0.51) RAB9AADORA2APOLBADORA3ADORA2B
SCHEMBL26369966 0.74 ERCC1 (0.47) MAPTGAANPC1KDM4EALDH1A1
SCHEMBL27884124 0.74 MAPT (0.44) RAB9AMAPTPOLBGAANPC1
SCHEMBL3421554 0.74 RAB9A (0.66) RAB9AMAPTADORA2APOLBADORA3
SCHEMBL6980235 0.72 ADORA2A (0.72) RAB9AMAPTADORA2APOLBADORA3
SCHEMBL15021167 0.71 NPC1 (0.42) RAB9AMAPTGAANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed